“
TL;DR
This systematic review and meta-analysis of 138 studies found that awareness, treatment, and control rates for hypertension, dyslipidemia, and diabetes mellitus were suboptimal across 11 Asia-Pacific countries.
Journal of Comparative Effectiveness Research · 4 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This systematic review and meta-analysis of 138 studies found that awareness, treatment, and control rates for hypertension, dyslipidemia, and diabetes mellitus were suboptimal across 11 Asia-Pacific countries.
The analysis found that individuals with dyslipidemia had the lowest pooled management rates. Limitations include heterogeneity in study designs and populations, and the lack of data for certain areas like Hong Kong.